PINK:SKYE

Skye Bioscience Stock Predictions

Healthcare > Biotechnology

Buy SKYE

*Your capital is at risk

$0.770

+0.0563 (+7.89%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

SKYE Prediction Chart

SKYE Predictions History

Latest community submissions for SKYE.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
mmp120685.233105	Apr 19, 2021	Bullish	Awaiting close	—	—	1
James Duran @JamesDuran.203187	Apr 19, 2021	Bullish	Awaiting close	—	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SKYE with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SKYE BIOSCIENCE, INC.

Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degenerati...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by